Year |
Citation |
Score |
2023 |
Maunye TK, Gededzha MP, Blackard JT, Rakgole JN, Selabe SG. Hepatitis C virus genotype 5 variability in treatment naïve patients in South Africa. Intervirology. PMID 37231989 DOI: 10.1159/000528178 |
0.436 |
|
2023 |
Tyler B, Meeds HL, Odegard EA, Ismael N, Vubil A, Zicai AF, Mabunda N, Blackard JT. Hepatitis B Virus Genotype E/A Recombinants from Blood Donors in Beira, Mozambique. Microbiology Resource Announcements. e0018223. PMID 37227284 DOI: 10.1128/mra.00182-23 |
0.36 |
|
2023 |
Madhuravasal Krishnan J, Kong L, Karns R, Medvedovic M, Sherman KE, Blackard JT. The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines. Viruses. 15. PMID 37113007 DOI: 10.3390/v15041027 |
0.34 |
|
2023 |
Mathew A, Ismael N, Meeds H, Vubil A, Zicai AF, Mabunda N, Blackard JT. Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique. Plos One. 18: e0281855. PMID 36795797 DOI: 10.1371/journal.pone.0281855 |
0.381 |
|
2022 |
Kong L, Shata MTM, Brown JL, Lyons MS, Sherman KE, Blackard JT. The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro. Journal of Neurovirology. PMID 35976538 DOI: 10.1007/s13365-022-01090-3 |
0.332 |
|
2021 |
Blackard JT, Sherman KE. Drugs of Abuse and Their Impact on Viral Pathogenesis. Viruses. 13. PMID 34960656 DOI: 10.3390/v13122387 |
0.399 |
|
2021 |
Olagbenro M, Anderson M, Gaseitsiwe S, Powell EA, Gededzha MP, Selabe SG, Blackard JT. In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa. Archives of Virology. PMID 34468889 DOI: 10.1007/s00705-021-05196-7 |
0.324 |
|
2021 |
Zimmerman J, Blackard JT. Human pegivirus type 1 infection in Asia-A review of the literature. Reviews in Medical Virology. e2257. PMID 34038600 DOI: 10.1002/rmv.2257 |
0.424 |
|
2021 |
Kong L, Karns R, Shata MTM, Brown JL, Lyons MS, Sherman KE, Blackard JT. The synthetic opioid fentanyl enhances viral replication in vitro. Plos One. 16: e0249581. PMID 33852610 DOI: 10.1371/journal.pone.0249581 |
0.393 |
|
2020 |
Phinius BB, Anderson M, Bhebhe L, Baruti K, Manowe G, Choga WT, Mupfumi L, Mbangiwa T, Mudanga M, Moyo S, Marlink R, Blackard JT, Gaseitsiwe S. Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana. Pathogens (Basel, Switzerland). 9. PMID 33202597 DOI: 10.3390/pathogens9110950 |
0.428 |
|
2020 |
Mabunda N, Zicai AF, Ismael N, Vubil A, Mello F, Blackard JT, Lago B, Duarte V, Moraes M, Lewis L, Jani I. Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique. Memorias Do Instituto Oswaldo Cruz. 115: e200006. PMID 32997000 DOI: 10.1590/0074-02760200006 |
0.33 |
|
2020 |
Baruti K, Lentz K, Anderson M, Ajibola G, Phinius BB, Choga WT, Mbangiwa T, Powis KM, Sebunya T, Blackard JT, Lockman S, Moyo S, Shapiro R, Gaseitsiwe S. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana. Plos One. 15: e0237252. PMID 32764801 DOI: 10.1371/Journal.Pone.0237252 |
0.443 |
|
2020 |
Ngwaga T, Kong L, Lin D, Schoborg C, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC, Tavis JE, Blackard JT. Diversity of the hepatitis C virus NS5B gene during HIV co-infection. Plos One. 15: e0237162. PMID 32750098 DOI: 10.1371/Journal.Pone.0237162 |
0.583 |
|
2020 |
Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses. 12. PMID 32640609 DOI: 10.3390/V12070731 |
0.419 |
|
2020 |
Lukhwareni A, Gededzha MP, Amponsah-Dacosta E, Blackard JT, Burnett RJ, Selabe SG, Kyaw T, Mphahlele MJ. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans. Viruses. 12. PMID 32545313 DOI: 10.3390/V12060634 |
0.579 |
|
2020 |
Blackard JT, Davies SM, Laskin BL. BK polyomavirus diversity-Why viral variation matters. Reviews in Medical Virology. e2102. PMID 32128960 DOI: 10.1002/Rmv.2102 |
0.473 |
|
2020 |
Phinius BB, Anderson M, Bokete R, Mbangiwa T, Choga WT, Baruti K, Makhema J, Musonda R, Blackard JT, Essex M, Moyo S, Marlink R, Gaseitsiwe S. Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana. Medicine. 99: e19341. PMID 32118769 DOI: 10.1097/Md.0000000000019341 |
0.678 |
|
2020 |
Raheel M, Choga WT, Blackard JT. The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape. Journal of Medical Virology. PMID 32104912 DOI: 10.1002/Jmv.25730 |
0.367 |
|
2019 |
Protopapas S, Murrison LB, Wexelblatt SL, Blackard JT, Hall ES. Addressing the Disease Burden of Vertically Acquired Hepatitis C Virus Infection Among Opioid-Exposed Infants. Open Forum Infectious Diseases. 6: ofz448. PMID 32128320 DOI: 10.1093/Ofid/Ofz448 |
0.494 |
|
2019 |
Hammerstad SS, Blackard JT, Lombardi A, Owen RP, Concepcion E, Yi Z, Zhang W, Tomer Y. Hepatitis C virus infection of human thyrocytes: metabolic, hormonal, and immunological implications. The Journal of Clinical Endocrinology and Metabolism. PMID 31784757 DOI: 10.1210/Clinem/Dgz241 |
0.52 |
|
2019 |
Blackard JT, Kong L, Rouster SD, Karns R, Horn PS, Kottilil S, Shata MT, Sherman KE. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro. Plos One. 14: e0224523. PMID 31661521 DOI: 10.1371/Journal.Pone.0224523 |
0.554 |
|
2019 |
Bhebhe L, Anderson M, Souda S, Choga WT, Zumbika E, Shaver ZM, Mbangiwa T, Phinius BB, Banda CC, Melamu P, Musonda RM, Essex M, Blackard JT, Moyo S, Gaseitsiwe S. Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. Bmc Infectious Diseases. 19: 875. PMID 31640596 DOI: 10.1186/S12879-019-4514-1 |
0.625 |
|
2019 |
Blackard JT, Kwara A, Sherman KE. In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. Journal of Hepatology. PMID 31564447 DOI: 10.1016/J.Jhep.2019.07.010 |
0.368 |
|
2019 |
Boyce CL, Willis S, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT. Identification of hepatitis B virus genotype A/E recombinants in Ghana. Virus Genes. PMID 31346975 DOI: 10.1007/S11262-019-01690-Y |
0.538 |
|
2019 |
Makatini Z, Mda S, Towobola O, Mthiyane H, Miles P, Blackard JT. Characterisation of protease resistance mutations in a South African paediatric cohort with virological failure, 2011 - 2017. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 109: 511-515. PMID 31266578 DOI: 10.7196/Samj.2019.V109I7.13705 |
0.431 |
|
2019 |
Baxter C, Ngcapu S, Blackard JT, Powell EA, Penton PK, Abdool Karim SS. Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis. Viruses. 11. PMID 31248149 DOI: 10.3390/V11060569 |
0.458 |
|
2019 |
Blackard JT, Brown JL, Lyons MS. Synthetic opioid use and common injection-associated viruses:expanding the translational research agenda. Current Hiv Research. PMID 31210115 DOI: 10.2174/1570162X17666190618154534 |
0.465 |
|
2019 |
Sherman KE, Rouster SD, Kong LX, Aliota MT, Blackard JT, Dean GE. Zika virus replication and cytopathic effects in liver cells. Plos One. 14: e0214016. PMID 30893357 DOI: 10.1371/Journal.Pone.0214016 |
0.42 |
|
2019 |
Mbangiwa T, Melamu P, Molebatsi K, Anderson M, Bhebhe L, Moyo S, Phinius B, Choga W, Blackard JT, Kasvosve I, Kammerer B, Mayondi G, Lockman S, Gaseitsiwe S. Maternal Hepatitis B Virus Infection, Pregnancy, and Infant Health Outcomes in Botswana Hepatitis Monthly. 19. DOI: 10.5812/Hepatmon.95569 |
0.399 |
|
2018 |
Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S. Molecular characterization of hepatitis B virus in blood donors in Botswana. Virus Genes. PMID 30382563 DOI: 10.1007/S11262-018-1610-Z |
0.613 |
|
2018 |
Sherman KE, Abdel-Hameed E, Rouster SD, Shata MTM, Blackard JT, Safaie P, Kroner B, Preiss L, Horn PS, Kottilil S. Improvement in Hepatic Fibrosis Biomarkers Associated with Chemokine Receptor Inactivation through Mutation or Therapeutic Blockade. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30239650 DOI: 10.1093/Cid/Ciy807 |
0.536 |
|
2018 |
Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana. Genes. 9. PMID 30205537 DOI: 10.3390/Genes9090453 |
0.669 |
|
2018 |
Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm. Genes. 9. PMID 30134551 DOI: 10.3390/Genes9090420 |
0.532 |
|
2018 |
Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, et al. Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana. Genes. 9. PMID 29772814 DOI: 10.3390/Genes9050259 |
0.649 |
|
2018 |
Sherman KE, Rouster SD, Kong LX, Shata TM, Archampong T, Kwara A, Aliota MT, Blackard JT. Zika Virus Exposure in an HIV-Infected Cohort in Ghana. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29771784 DOI: 10.1097/Qai.0000000000001718 |
0.535 |
|
2018 |
Blackard JT, Sherman KE. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). Reviews in Medical Virology. e1984. PMID 29761585 DOI: 10.1002/Rmv.1984 |
0.54 |
|
2018 |
N'Guessan KF, Boyce C, Kwara A, Archampong TNA, Lartey M, Sagoe KW, Kenu E, Obo-Akwa A, Blackard JT. Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Virus Genes. PMID 29551002 DOI: 10.1007/S11262-018-1555-2 |
0.591 |
|
2018 |
Gededzha MP, Sondlane TH, Malinga LA, Burnett RJ, Lebelo RL, Blackard JT, Mphahlele MJ, Selabe SG. Molecular characterization of hepatitis B virus X gene in HIV-positive South Africans. Virus Genes. PMID 29411271 DOI: 10.1007/S11262-018-1536-5 |
0.493 |
|
2018 |
Blackard JT. A39 Genetic diversity of the hepatitis C virus NS5B gene during HIV/HCV co-infection Virus Evolution. 4. DOI: 10.1093/Ve/Vey010.038 |
0.581 |
|
2017 |
Blackard JT, Kong L, Lombardi A, Homann D, Hammerstad SS, Tomer Y. A preliminary analysis of hepatitis C virus in pancreatic islet cells. Virology Journal. 14: 237. PMID 29258547 DOI: 10.1186/S12985-017-0905-3 |
0.504 |
|
2017 |
N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana. Open Forum Infectious Diseases. 4: ofx222. PMID 29255726 DOI: 10.1093/Ofid/Ofx222 |
0.632 |
|
2017 |
Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M, Schoech M, Safdar K, Blackard JT, Apewokin S, Paterno F, Sherman KE, Zucker SD, Anwar N, Shah SA. Hepatitis C Transmission from Seropositive, Non-Viremic Donors to Non-Hepatitis C Liver Transplant Recipients. Hepatology (Baltimore, Md.). PMID 29205441 DOI: 10.1002/Hep.29704 |
0.436 |
|
2017 |
Singh S, Blackard JT. Human pegivirus (HPgV) infection in sub-Saharan Africa-A call for a renewed research agenda. Reviews in Medical Virology. PMID 29148108 DOI: 10.1002/Rmv.1951 |
0.491 |
|
2017 |
Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases. 4: ofx195. PMID 29062862 DOI: 10.1093/Ofid/Ofx195 |
0.686 |
|
2017 |
Saha D, Pal A, Sarkar N, Das D, Blackard JT, Guha SK, Saha B, Chakravarty R. Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India. Plos One. 12: e0179035. PMID 28591184 DOI: 10.1371/Journal.Pone.0179035 |
0.569 |
|
2017 |
Boyce CL, Ganova-Raeva L, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT. Identification and comparative analysis of hepatitis B virus genotype D/E recombinants in Africa. Virus Genes. PMID 28567562 DOI: 10.1007/S11262-017-1469-4 |
0.44 |
|
2017 |
Petronella Gededzha M, Mphahlele MJ, Blackard JT, Gloria Selabe S. Prevalence of NS5B Resistance Mutations in Hepatitis C Virus (HCV) Treatment Naive South Africans Hepatitis Monthly. 17. DOI: 10.5812/Hepatmon.14248 |
0.497 |
|
2016 |
Hammerstad SS, Stefan M, Blackard J, Owen RP, Lee HJ, Concepcion E, Yi Z, Zhang W, Tomer Y. HEPATITIS C VIRUS E2 PROTEIN INDUCES UPREGULATION OF IL-8 PATHWAYS AND PRODUCTION OF HEAT SHOCK PROTEINS IN HUMAN THYROID CELLS. The Journal of Clinical Endocrinology and Metabolism. jc20163403. PMID 27860532 DOI: 10.1210/Jc.2016-3403 |
0.476 |
|
2016 |
Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases. 3: ofw140. PMID 27800524 DOI: 10.1093/Ofid/Ofw140 |
0.688 |
|
2016 |
Woltmann J, Burke P, Brady R, Blackard JT. Demographics of Hepatitis C in Southwest Ohio (2010 to 2015). Hepatitis Monthly. 16: e37904. PMID 27799964 DOI: 10.5812/Hepatmon.37904 |
0.484 |
|
2016 |
Amponsah-Dacosta E, Rakgole JN, Gededzha MP, Blackard JT, Selabe SG, Mphahlele MJ. Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 27245151 DOI: 10.1016/J.Meegid.2016.05.035 |
0.559 |
|
2016 |
Archampong TN, Boyce CL, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Blackard JT, Kwara A. HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients. Antiviral Therapy. PMID 27167598 DOI: 10.3851/Imp3055 |
0.542 |
|
2016 |
Powell EA, Razeghi S, Zucker S, Blackard JT. Occult Hepatitis B Virus Infection in a Previously Vaccinated Injection Drug User. Hepatitis Monthly. 16: e34758. PMID 27148386 DOI: 10.5812/Hepatmon.34758 |
0.426 |
|
2016 |
Blackard JT, Ma G, Polen C, DuBois JC, Gast J, Radens CM, Sterling RK, Sherman KE. Recombination among GB virus C (GBV-C) isolates in the United States. The Journal of General Virology. PMID 27072634 DOI: 10.1099/Jgv.0.000477 |
0.486 |
|
2016 |
Powell EA, Boyce CL, Gededzha MP, Selabe SG, Mphahlele MJ, Blackard JT. Functional Analysis of "a" Determinant Mutations Associated with Occult HBV in HIV-Positive South Africans. The Journal of General Virology. PMID 27031988 DOI: 10.1099/Jgv.0.000469 |
0.451 |
|
2016 |
Prabdial-Sing N, Blackard JT, Puren AJ, Mahomed A, Abuelhassan W, Mahlangu J, Vermeulen M, Bowyer SM. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa. Antiviral Research. 127: 90-8. PMID 26704023 DOI: 10.1016/J.Antiviral.2015.11.011 |
0.416 |
|
2016 |
Amponsah-Dacosta E, Rakgole JN, Gadedzaha M, Blackard J, Selabe S, Mphahlele J. Genetic variability and molecular evolution of Hepatitis B virus in HIV co-infected patients onlamivudine-based anti-retroviral therapy: a 5 year South African longitudinal study F1000research. 5. DOI: 10.7490/F1000Research.1111602.1 |
0.54 |
|
2016 |
Amponsah-Dacosta E, Selabe G, Gededzha M, Rakgole J, Blackard J, Mphahlele J. Genetic variability and molecular evolution of hepatitis B virus in HIV co-infected patients on lamivudine based anti-retroviral therapy: A 5 year longitudinal study International Journal of Infectious Diseases. 45: 456. DOI: 10.1016/J.Ijid.2016.02.966 |
0.542 |
|
2015 |
Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. Bmc Infectious Diseases. 15: 335. PMID 26268355 DOI: 10.1186/S12879-015-1096-4 |
0.675 |
|
2015 |
Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Selabe SG, Gededzha MP, Mayaphi SH, Powell EA, Blackard JT, Mphahlele MJ. Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 63: 12-7. PMID 25600597 DOI: 10.1016/J.Jcv.2014.11.032 |
0.479 |
|
2015 |
Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, Mphahlele MJ, Blackard JT. Mutations associated with occult hepatitis B in HIV-positive South Africans. Journal of Medical Virology. 87: 388-400. PMID 25164924 DOI: 10.1002/Jmv.24057 |
0.484 |
|
2015 |
Anderson M, Gaseitsiwe S, Moyo S, Wessels MJC, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana Bmc Infectious Diseases. 15. DOI: 10.1186/s12879-015-1096-4 |
0.647 |
|
2015 |
Ryan K, Anderson M, Gaseitsiwe S, Blackard J. Occult and Chronic Hepatitis B in HIV-Positive Batswana Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1231 |
0.524 |
|
2015 |
Sherman K, Kong L, Blackard J. P0906 : Inhibition of HCV replication by CCR5 blockade with cenicriviroc and maraviroc Journal of Hepatology. 62: S684. DOI: 10.1016/S0168-8278(15)31109-0 |
0.417 |
|
2014 |
Blackard JT, Ma G, Welge JA, King CC, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, Gardner L. GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection. Plos One. 9: e114467. PMID 25493916 DOI: 10.1371/Journal.Pone.0114467 |
0.505 |
|
2014 |
Sherman KE, Guedj J, Shata MT, Blackard JT, Rouster SD, Castro M, Feinberg J, Sterling RK, Goodman Z, Aronow BJ, Perelson AS. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Science Translational Medicine. 6: 246ra98. PMID 25101888 DOI: 10.1126/Scitranslmed.3008195 |
0.574 |
|
2014 |
Blackard JT, Ma G, Sengupta S, Martin CM, Powell EA, Shata MT, Sherman KE. Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. Journal of Medical Virology. 86: 1332-41. PMID 24788693 DOI: 10.1002/Jmv.23968 |
0.577 |
|
2014 |
Kong L, Welge JA, Powell EA, Blackard JT. HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro. Plos One. 9: e83728. PMID 24586227 DOI: 10.1371/Journal.Pone.0083728 |
0.578 |
|
2014 |
Gededzha MP, Selabe SG, Blackard JT, Kyaw T, Mphahlele MJ. Near full-length genome analysis of HCV genotype 5 strains from South Africa. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 21: 118-23. PMID 24220189 DOI: 10.1016/J.Meegid.2013.10.022 |
0.437 |
|
2014 |
Penton PK, Blackard JT. Analysis of HIV quasispecies suggests compartmentalization in the liver. Aids Research and Human Retroviruses. 30: 394-402. PMID 24074301 DOI: 10.1089/AID.2013.0146 |
0.434 |
|
2014 |
Anderson M, Gaseitsiwe S, Moyo S, Mohammed T, Sebunya TK, Blackard J, Makhema J, Essex M, Musonda R. Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana Bmc Infectious Diseases. 14. DOI: 10.1186/1471-2334-14-S2-P86 |
0.696 |
|
2013 |
Mayaphi SH, Martin DJ, Mphahlele MJ, Blackard JT, Bowyer SM. Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV Journal of Medical Virology. 85: 1883-1892. PMID 23925707 DOI: 10.1002/Jmv.23695 |
0.528 |
|
2013 |
Sengupta S, Powell E, Kong L, Blackard JT. Effects of HCV on basal and tat-induced HIV LTR activation. Plos One. 8: e64956. PMID 23762271 DOI: 10.1371/Journal.Pone.0064956 |
0.592 |
|
2013 |
Kong L, Blackard JT. Interferon alfa partially inhibits HIV replication in hepatocytes in vitro. The Journal of Infectious Diseases. 208: 865-6. PMID 23757338 DOI: 10.1093/Infdis/Jit255 |
0.473 |
|
2013 |
Blackard JT, Kong L, Huber AK, Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid : Official Journal of the American Thyroid Association. 23: 863-70. PMID 23259732 DOI: 10.1089/Thy.2012.0507 |
0.494 |
|
2013 |
Blackard JT, Martin CM, Sengupta S, Forrester J. Limited infection with occult hepatitis B virus in drug users in the USA. Hepatology Research : the Official Journal of the Japan Society of Hepatology. 43: 413-7. PMID 22909008 DOI: 10.1111/J.1872-034X.2012.01072.X |
0.425 |
|
2012 |
Blackard JT. HCV superinfection and reinfection. Antiviral Therapy. 17: 1443-8. PMID 23221168 DOI: 10.3851/Imp2460 |
0.488 |
|
2012 |
Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard JT. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. Journal of Viral Hepatitis. 19: 716-23. PMID 22967103 DOI: 10.1111/J.1365-2893.2012.01595.X |
0.472 |
|
2012 |
Kong L, Cardona Maya W, Moreno-Fernandez ME, Ma G, Shata MT, Sherman KE, Chougnet C, Blackard JT. Low-level HIV infection of hepatocytes. Virology Journal. 9: 157. PMID 22877244 DOI: 10.1186/1743-422X-9-157 |
0.485 |
|
2012 |
Schwarze-Zander C, Blackard JT, Rockstroh JK. Role of GB virus C in modulating HIV disease. Expert Review of Anti-Infective Therapy. 10: 563-72. PMID 22702320 DOI: 10.1586/Eri.12.37 |
0.562 |
|
2012 |
Gededzha MP, Selabe SG, Kyaw T, Rakgole JN, Blackard JT, Mphahlele MJ. Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa. Journal of Medical Virology. 84: 601-7. PMID 22337299 DOI: 10.1002/Jmv.23215 |
0.465 |
|
2012 |
Blackard JT. HIV compartmentalization: a review on a clinically important phenomenon. Current Hiv Research. 10: 133-42. PMID 22329519 DOI: 10.2174/157016212799937245 |
0.493 |
|
2012 |
Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. Journal of Medical Virology. 84: 242-52. PMID 22170544 DOI: 10.1002/Jmv.22269 |
0.504 |
|
2011 |
Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. Aids Patient Care and Stds. 25: 571-7. PMID 21859307 DOI: 10.1089/Apc.2011.0106 |
0.541 |
|
2011 |
Martin CM, Welge JA, Blackard JT. Hepatitis B virus (HBV) X gene diversity and evidence of recombination in HBV/HIV co-infected persons. Journal of Medical Virology. 83: 1142-50. PMID 21520141 DOI: 10.1002/Jmv.22090 |
0.556 |
|
2011 |
Blackard JT, Ma G, Martin CM, Rouster SD, Shata MT, Sherman KE. HIV variability in the liver and evidence of possible compartmentalization. Aids Research and Human Retroviruses. 27: 1117-26. PMID 21417757 DOI: 10.1089/Aid.2010.0329 |
0.457 |
|
2011 |
Neibecker M, Schwarze-Zander C, Rockstroh JK, Spengler U, Blackard JT. Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany. Journal of Medical Virology. 83: 685-94. PMID 21328384 DOI: 10.1002/Jmv.22029 |
0.435 |
|
2011 |
Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 674-80. PMID 21248367 DOI: 10.1093/Cid/Ciq199 |
0.586 |
|
2011 |
Schwarze-Zander C, Blackard JT, Spengler U, Rockstroh JK. A review of GB virus C co-infection in advanced HIV type-1 disease European Infectious Disease. 5: 27-30. |
0.419 |
|
2010 |
Blackard JT, Ma G, Limketkai BN, Welge JA, Dryer PD, Martin CM, Hiasa Y, Taylor LE, Mayer KH, Jamieson DJ, Sherman KE. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. Journal of Clinical Microbiology. 48: 4256-9. PMID 20810773 DOI: 10.1128/Jcm.01613-10 |
0.458 |
|
2010 |
Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler U. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antiviral Therapy. 15: 745-52. PMID 20710056 DOI: 10.3851/Imp1602 |
0.485 |
|
2010 |
Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. The Journal of Infectious Diseases. 201: 712-9. PMID 20105080 DOI: 10.1086/650490 |
0.575 |
|
2010 |
Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, Blackard JT. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. Journal of Viral Hepatitis. 17: 588-97. PMID 19889143 DOI: 10.1111/J.1365-2893.2009.01214.X |
0.519 |
|
2009 |
Moreno-Fernandez ME, Zapata W, Blackard JT, Franchini G, Chougnet CA. Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. Journal of Virology. 83: 12925-33. PMID 19828616 DOI: 10.1128/Jvi.01352-09 |
0.507 |
|
2009 |
Dryer PD, Limketkai BN, Martin CM, Ma G, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ, Blackard JT. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. The Journal of Antimicrobial Chemotherapy. 64: 945-8. PMID 19767319 DOI: 10.1093/Jac/Dkp328 |
0.461 |
|
2009 |
Blackard JT, Rouster SD, Nady S, Galal G, Marzuuk N, Rafaat MM, Daef E, El Din SS, Purcell RH, Emerson SU, Sherman KE, Shata MT. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 46: 140-4. PMID 19651539 DOI: 10.1016/J.Jcv.2009.07.007 |
0.496 |
|
2009 |
Martin CM, Welge JA, Shire NJ, Shata MT, Sherman KE, Blackard JT. Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine. 47: 194-8. PMID 19625194 DOI: 10.1016/J.Cyto.2009.06.005 |
0.464 |
|
2008 |
Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. Journal of Autoimmunity. 31: 339-44. PMID 18799285 DOI: 10.1016/J.Jaut.2008.08.001 |
0.389 |
|
2008 |
Blackard JT, Welles SL, Ackerman A, Kalia N, Cohen DE, Mayer KH. Immunological rebound after initiation of highly active antiretroviral therapy in treatment-naive patients. Aids Research and Human Retroviruses. 24: 499-504. PMID 18373435 DOI: 10.1089/Aid.2007.0099 |
0.395 |
|
2008 |
Blackard JT, Sherman KE. HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver? Journal of Viral Hepatitis. 15: 323-330. PMID 18208497 DOI: 10.1111/J.1365-2893.2008.00970.X |
0.613 |
|
2008 |
Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem. Hepatology (Baltimore, Md.). 47: 321-31. PMID 18161707 DOI: 10.1002/Hep.21902 |
0.504 |
|
2007 |
Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinology and Metabolism Clinics of North America. 36: 1051-66; x-xi. PMID 17983936 DOI: 10.1016/J.Ecl.2007.07.001 |
0.373 |
|
2007 |
Blackard JT, Hiasa Y, Smeaton L, Jamieson DJ, Rodriguez I, Mayer KH, Chung RT. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. The Journal of Infectious Diseases. 195: 1765-73. PMID 17492592 DOI: 10.1086/518251 |
0.546 |
|
2007 |
Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 263-9. PMID 17477814 DOI: 10.1089/Jir.2006.0147 |
0.573 |
|
2007 |
Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. The Journal of Infectious Diseases. 195: 519-24. PMID 17230411 DOI: 10.1086/510858 |
0.508 |
|
2007 |
Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 309-14. PMID 17159656 DOI: 10.1097/Qai.0B013E31802E29A9 |
0.541 |
|
2006 |
Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 834-8. PMID 17115902 DOI: 10.1089/Jir.2006.26.834 |
0.503 |
|
2006 |
Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, Holtzman MJ, Chung RT. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. Journal of Virology. 80: 9226-35. PMID 16940534 DOI: 10.1128/Jvi.00459-06 |
0.42 |
|
2006 |
Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. The Journal of Infectious Diseases. 194: 410-9. PMID 16845623 DOI: 10.1086/505713 |
0.577 |
|
2006 |
Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (Baltimore, Md.). 44: 15-22. PMID 16799966 DOI: 10.1002/Hep.21283 |
0.498 |
|
2006 |
Koulinska IN, Villamor E, Msamanga G, Fawzi W, Blackard J, Renjifo B, Essex M. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. Virus Research. 120: 191-8. PMID 16621098 DOI: 10.1016/J.Virusres.2006.03.007 |
0.616 |
|
2006 |
Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccalà G, Chung RT. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. Journal of Medical Virology. 78: 202-7. PMID 16372286 DOI: 10.1002/Jmv.20528 |
0.534 |
|
2006 |
Hiasa Y, Blackard JT, Lin W, Kamegaya Y, Horiike N, Onji M, Schmidt EV, Chung RT. Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication. Journal of Virological Methods. 132: 195-203. PMID 16313977 DOI: 10.1016/J.Jviromet.2005.10.014 |
0.486 |
|
2006 |
Shata M, Barrett A, Rouster S, Shire N, Blackard J, Atiq M, Engle R, Purcell R, Emerson S, Strickland G, Sherman K. P.312 Isolation and characterization of hepatitis E virus (HEV)-specific T cell clones from an asymptomatic HEV-exposed subject Journal of Clinical Virology. 36: S158. DOI: 10.1016/S1386-6532(06)80488-9 |
0.391 |
|
2005 |
Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, Jamieson DJ, Rodriguez I, Mayer KH, Chung RT. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. The Journal of Infectious Diseases. 192: 258-65. PMID 15962220 DOI: 10.1086/430949 |
0.51 |
|
2005 |
Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RT. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology. 128: 1034-41. PMID 15825084 DOI: 10.1053/J.Gastro.2005.02.006 |
0.461 |
|
2005 |
Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology (Baltimore, Md.). 41: 660-7. PMID 15723444 DOI: 10.1002/Hep.20621 |
0.36 |
|
2004 |
Blackard JT, Yang Y, Bordoni P, Sherman KE, Chung RT. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. The Journal of Infectious Diseases. 189: 1472-81. PMID 15073685 DOI: 10.1086/382959 |
0.577 |
|
2004 |
Blackard JT, Mayer KH. HIV superinfection in the era of increased sexual risk-taking. Sexually Transmitted Diseases. 31: 201-4. PMID 15028931 DOI: 10.1097/01.Olq.0000118082.45312.1F |
0.443 |
|
2003 |
Meyer-Olson D, Brady KW, Blackard JT, Allen TM, Islam S, Shoukry NH, Hartman K, Walker CM, Kalams SA. Analysis of the TCR beta variable gene repertoire in chimpanzees: identification of functional homologs to human pseudogenes. Journal of Immunology (Baltimore, Md. : 1950). 170: 4161-9. PMID 12682248 DOI: 10.4049/Jimmunol.170.8.4161 |
0.399 |
|
2003 |
ZANDER C, ANDERSEN J, BLACKARD J, LIN W, ZDUNEK D, HESS G, PETERS M, KOZIEL M, SHERMAN K, ROBBINS G. 1066 GB virus-C clearance is frequent in HIV/HCV co-infected patients receiving interferon and ribavirin treatment but does not adversely affect HIV-1 viremia: the adult ACTG A5071 study group Hepatology. 38: 669-669. DOI: 10.1016/S0270-9139(03)81104-7 |
0.572 |
|
2003 |
BLACKARD J. 629 Hepatitis C virus (HCV) diversity in HIV-HCV co-infected persons initiating antiretroviral therapy Hepatology. 38: 464-464. DOI: 10.1016/S0270-9139(03)80671-7 |
0.587 |
|
2003 |
KAMEGAYA Y, HIASA Y, ZUKERBERG L, FOWLER N, BLACKARD J, LIN W, SCHMIDT E, CHUNG R. 502 HCV core-E1-E2 acts as an HCC tumor accelerator through suppression of apoptosis Hepatology. 38: 401-401. DOI: 10.1016/S0270-9139(03)80544-X |
0.346 |
|
2003 |
HIASA Y, BLACKARD J, KAMEGAYA Y, HORIIKE N, ONJI M, SCHMIDT E, CHUNG R. 415 Sustained, interferon-sensitive HCV replication in a cell-based HCV replication model using replication defective adenoviral vectors or stable cell lines expressing T7 polymerase Hepatology. 38: 360-360. DOI: 10.1016/S0270-9139(03)80458-5 |
0.423 |
|
2003 |
LIN W, HIASA Y, KAMEGAYA Y, BLACKARD J, ZANDER C, BECK G, SCHMIDT E, CHUNG R. 31 HCV expression inhibits interferon signaling in a cell-based HCV replication model Hepatology. 38: 170-170. DOI: 10.1016/S0270-9139(03)80074-5 |
0.422 |
|
2002 |
Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 1108-14. PMID 11915000 DOI: 10.1086/339547 |
0.463 |
|
2001 |
Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, Hunter D, Spiegelman D, Sharghi N, Kagoma C, Essex M. HIV-1 LTR subtype and perinatal transmission. Virology. 287: 261-5. PMID 11531404 DOI: 10.1006/Viro.2001.1059 |
0.576 |
|
2000 |
Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, Essex M. Diversity of the HIV-1 long terminal repeat following mother-to-child transmission. Virology. 274: 402-11. PMID 10964782 DOI: 10.1006/Viro.2000.0466 |
0.53 |
|
2000 |
Choudhury S, Montano MA, Womack C, Blackard JT, Maniar JK, Saple DG, Tripathy S, Sahni S, Shah S, Babu GP, Essex M. Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India Journal of Human Virology. 3: 35-43. PMID 10774805 |
0.534 |
|
1999 |
Renjifo B, Blackard JT, Klaskala W, Chaplin BR, Shah P, McLane MF, Barin F, Esparza J, Zelaya JE, Osmanov S, Soto R, Fernandez JA, Baum MK, Essex ME. HIV-1 subtype B in Honduras. Virus Research. 60: 191-7. PMID 10392727 DOI: 10.1016/S0168-1702(99)00014-3 |
0.581 |
|
1999 |
Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, Essex M. Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology. 254: 220-5. PMID 9986788 DOI: 10.1006/Viro.1998.9504 |
0.603 |
|
1998 |
Maeda N, Kawamura T, Hoshino H, Yamada N, Blackard J, Kushida S, Miyano-Kurosaki N, Yamamoto N, Makino K, Yokota T, Uchida K, Miwa M. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide. Biochemical and Biophysical Research Communications. 243: 109-12. PMID 9473488 DOI: 10.1006/Bbrc.1997.8039 |
0.327 |
|
1997 |
Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. Journal of Virology. 71: 8657-65. PMID 9343223 DOI: 10.1128/Jvi.71.11.8657-8665.1997 |
0.612 |
|
Show low-probability matches. |